Syndax Pharmaceuticals (SNDX) Tops Q1 EPS by 6c

Syndax Pharmaceuticals (NASDAQ: SNDX) reported Q1 EPS of ($0.59), $0.06 better than the analyst estimate of ($0.65). Revenue for the quarter came in at $0 versus the consensus estimate of $800 thousand.

For earnings history and earnings-related data on Syndax Pharmaceuticals (SNDX) click here.

You May Also Be Interested In

• ​Trump said he was unaware of his earnings from crypto
• Syndax Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
• Elevance (ELV) PT Raised to $482 at Bernstein SocGen